Expression of fibrinolytic antigens in redistributed cardiac mast cells in auricular thrombosis

被引:9
作者
Bankl, HC
Radaszkiewicz, T
Pikula, B
Baghestanian, M
Mehrabi, MR
Bankl, H
Lechner, K
Valent, P
机构
[1] UNIV VIENNA,DEPT INTERNAL MED 2,DIV CARDIOL,A-1090 VIENNA,AUSTRIA
[2] UNIV VIENNA,DEPT INTERNAL MED 1,DIV HEMATOL & HEMOSTASEOL,A-1090 VIENNA,AUSTRIA
[3] KRANKENHAUS ST POELTEN,INST CLIN PATHOL,ST POLTEN,AUSTRIA
基金
奥地利科学基金会;
关键词
mast cells; auricular thrombosis; fibrinolysis; stem cell factor;
D O I
10.1016/S0046-8177(97)90202-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Recent data suggest that auricular thrombosis is associated with an increase and accumulation of mast cells (MC) in the subendothelial region of the upper endocardium. However, the molecular basis and the functional role of MC in this process are not known. In the current study, expression of fibrinolytic and antifibrinolytic antigens in human cardiac MC was analyzed by immunohistochemistry. MC were found to react with antibodies against tissue-type plasminogen activator (tPA) and urokinase receptor (uPAR/CD87), but not with antibodies against urokinase (uPA) or plasminogen activator inhibitors (PAI-1, PAI-2). Significant changes were observed when the phenotype of accumulated MC in the upper endocardium in patients with auricular thrombosis was compared with the phenotype of myocardial MC in the same patients or with MC in normal hearts. These redistributed MC stained less intensely with antibodies against tPA and chymase but retained their staining for tryptase and uPAR. Together, these data indicate that cardiac MC are a source of fibrinolytic antigens and that accumulation of MC in auricular thrombosis is associated with phenotypic changes of MC and loss of cellular tPA. It is hypothesized that MC and their products may play a role in endogenous fibrinolysis in auricular thrombosis. Copyright (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:1283 / 1290
页数:8
相关论文
共 33 条
  • [1] Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes
    Agis, H
    Fureder, W
    Bankl, HC
    Kundi, M
    Sperr, WR
    Willheim, M
    BoltzNitulescu, G
    Butterfield, JH
    Kishi, K
    Lechner, K
    Valent, P
    [J]. IMMUNOLOGY, 1996, 87 (04) : 535 - 543
  • [2] INCREASE AND REDISTRIBUTION OF CARDIAC MAST-CELLS IN AURICULAR THROMBOSIS - POSSIBLE ROLE OF KIT-LIGAND
    BANKL, HC
    RADASZKIEWICZ, T
    KLAPPACHER, GW
    GLOGAR, D
    SPERR, WR
    GROSSSCHMIDT, K
    BANKL, H
    LECHNER, K
    VALENT, P
    [J]. CIRCULATION, 1995, 91 (02) : 275 - 283
  • [3] C-KIT LIGAND - A UNIQUE POTENTIATOR OF MEDIATOR RELEASE BY HUMAN LUNG MAST-CELLS
    BISCHOFF, SC
    DAHINDEN, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) : 237 - 244
  • [4] INDUCTION OF CELL-MIGRATION BY PROUROKINASE BINDING TO ITS RECEPTOR - POSSIBLE MECHANISM FOR SIGNAL-TRANSDUCTION IN HUMAN EPITHELIAL-CELLS
    BUSSO, N
    MASUR, SK
    LAZEGA, D
    WAXMAN, S
    OSSOWSKI, L
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 126 (01) : 259 - 270
  • [5] ESTABLISHMENT OF AN IMMATURE MAST-CELL LINE FROM A PATIENT WITH MAST-CELL LEUKEMIA
    BUTTERFIELD, JH
    WEILER, D
    DEWALD, G
    GLEICH, GJ
    [J]. LEUKEMIA RESEARCH, 1988, 12 (04) : 345 - 355
  • [6] MACROPHAGE FIBRINOLYTIC-ACTIVITY - IDENTIFICATION OF 2 PATHWAYS OF PLASMIN FORMATION BY INTACT-CELLS AND OF A PLASMINOGEN-ACTIVATOR INHIBITOR
    CHAPMAN, HA
    VAVRIN, Z
    HIBBS, JB
    [J]. CELL, 1982, 28 (03) : 653 - 662
  • [7] CONESE M, 1995, BIOL CHEM H-S, V376, P143
  • [8] CRAIG SS, 1993, LAB INVEST, V69, P552
  • [9] PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER
    DANO, K
    ANDREASEN, PA
    GRONDAHLHANSEN, J
    KRISTENSEN, P
    NIELSEN, LS
    SKRIVER, L
    [J]. ADVANCES IN CANCER RESEARCH, 1985, 44 : 139 - 266
  • [10] Cytokines and thrombosis
    Dosquet, C
    Weill, D
    Wautier, JL
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 : S13 - S19